Biotest AG Overview
Company Headquarters: Germany
Founded: 1946
Workforce: ~ 1,959
Company Working: Biotest AG is a Germany-based provider of plasma proteins and biological drugs. The Company, with a chain that extends from pre-clinical and clinical development to worldwide marketing and distribution, mainly specializes in the areas of clinical immunology, hematology, and intensive care medicine. Biotest AG develops, manufactures, and markets immunoglobulin, coagulation factors and albumins based on human blood plasma. These are used for diseases of the immune and hematopoietic systems. In addition, the Company develops monoclonal antibodies in the indications of cancer of plasma cells and systemic lupus erythematosus, which are produced by recombinant technologies. Barcelona-based Grifols, a global leader in plasma-derived medicines, today announced the completion of the acquisition of Biotest AG, a European healthcare company specialized in innovative hematology and clinical immunology.
Strategy
biological medicines. The company's strategy is focused on sustainable growth through innovation and expansion into new markets.
Some key elements of Biotest AG's strategy include:
Research and Development: Biotest AG invests heavily in research and development to drive innovation and stay ahead of the competition. The company has a strong pipeline of new products, including novel therapies for rare diseases.
International Expansion: Biotest AG has a global presence, with subsidiaries and production sites in Europe, Asia, and the Americas. The company continues to expand into new markets, particularly in emerging economies.
Partnerships and Collaborations: Biotest AG partners with other companies and organizations to advance its research and development programs and expand its product portfolio. The company has collaborations with academic institutions and biotech companies, as well as partnerships with pharmaceutical companies for co-development and co-marketing of products.
Operational Efficiency: Biotest AG continuously improves its operations to reduce costs and increase efficiency. The company has implemented lean manufacturing and quality management systems to streamline production and ensure product quality.
